Sunday, March 1

Economy

Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed.

Mideast Discourse is a news website specialised on the latest events and developments in the Middle East and the world, and it is in Both languages Arabic and English.

Advertisement
© 2026 MideastDiscourse. Designed by Somar kawkabi.